pk 11195 has been researched along with Cancer of Prostate in 4 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fafalios, A | 1 |
Akhavan, A | 1 |
Parwani, AV | 1 |
Bies, RR | 1 |
McHugh, KJ | 1 |
Pflug, BR | 1 |
Alenfall, J | 3 |
d'Argy, R | 1 |
Batra, S | 3 |
Kant, R | 1 |
4 other studies available for pk 11195 and Cancer of Prostate
Article | Year |
---|---|
Translocator protein blockade reduces prostate tumor growth.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma; Cell Death; Cell Proliferation; Cells, Cu | 2009 |
Whole-body autoradiographic study of [3H]-PK 11195 distribution in dunning AT-1 tumour-bearing rats.
Topics: Adrenal Cortex; Animals; Autoradiography; Chromatography, High Pressure Liquid; Isoquinolines; Male; | 1994 |
Characterization of peripheral benzodiazepine receptors in rat prostatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Benzodiazepinones; Binding, Competitive; Diazepam; Flunitrazepam; Isoquinol | 1994 |
Cytotoxic effects of 125I-labeled PBZr ligand PK 11195 in prostatic tumor cells: therapeutic implications.
Topics: Antineoplastic Agents; DNA Fragmentation; Electrophoresis, Agar Gel; Humans; Iodine Radioisotopes; I | 1998 |